Understanding how a gene loss helps cancer cells survive
Non-canonical Caspase-8 Activation on Autophagosomal Membranes
This study is looking at how a gene called VPS37A affects cancer cells and their ability to survive, especially when this gene is missing, which might help us understand better ways to treat cancer in the future.
Quick facts
| Grant type | R01 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Pennsylvania State Univ Hershey Med Ctr NIH-funded |
| Lab location | 1 site (Hershey, United States) |
| Project ID | NIH-11010845 on NIH RePORTER |
What this research studies
This research investigates the role of the VPS37A gene in cancer cell survival, particularly how its deficiency can lead to a survival advantage for these cells. The study focuses on the mechanisms involved in autophagy, a process that helps cells recycle components, and how the loss of VPS37A affects this process. By examining the interactions between VPS37A, the NF-κB signaling pathway, and other cellular components, the research aims to uncover new insights into cancer biology that could inform future therapies.
Who could benefit from this research
Good fit: Ideal candidates for this research are patients with solid tumors that exhibit VPS37A gene loss or related autophagy dysfunction.
Not a fit: Patients whose cancers do not involve VPS37A deficiency or those with non-solid tumors may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to new therapeutic strategies that target cancer cell survival mechanisms, potentially improving treatment outcomes for patients with solid tumors.
How similar studies have performed: Other research has shown promising results in targeting autophagy and related pathways in cancer treatment, suggesting that this approach may yield significant insights.
Where this research is happening
Hershey, United States
- Pennsylvania State Univ Hershey Med Ctr — Hershey, United States (Active)
Researchers
- Principal investigator: Wang, Hong-Gang — Pennsylvania State Univ Hershey Med Ctr
- Study coordinator: Wang, Hong-Gang
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.